Barely Significant
← all excerpts

Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic.

Pharmaceutics · 2020 · PMC7589819 · PMID 33092175

Europe PMCDOI
2
hedged sentences
0.0900
closest p · 1.8× alpha
0.0900
boldest claim

The sentences

did not reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)
27 months, respectively; however, this difference did not reach statistical significance ( Figure 2 C—Wilcoxon ChiSquare p = 0.09).

also in 111,027 other papers

a strong trendno p-value reported
Although not statistically significant, there was a strong trend for shorter survival for patients with EphA2-positive tumors compared to patients with negative tumors.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.